Merit Medical Systems | MMSI - Trade Debtors


Merit Medical Systems reported $227M in Trade Debtors for its fiscal quarter ending in March of 2026.





Trade Debtors Change Date
3M USD 3.75B 221M Mar/2026
Abbott USD 10.57B 171M Dec/2025
AngioDynamics USD 44.43M 1.79M Sep/2025
Anika Therapeutics USD 29.33M 661K Dec/2025
AtriCure USD 71.31M 4.66M Mar/2026
Baxter International USD 1.7B 310M Mar/2026
Becton, Dickinson and Co. USD 2.2B 303M Mar/2026
Boston Scientific USD 2.93B 98M Dec/2025
Cooper Companies USD 809.2M 2.1M Mar/2026
Dexcom USD 1.09B 182.1M Mar/2026
Edwards Lifesciences USD 912.1M 19.3M Dec/2025
Globus Medical USD 735.44M 8.23M Mar/2026
Haemonetics USD 195.71M 11.36M Dec/2025
ICU Medical USD 180.52M 11.03M Dec/2025
Insulet USD 544.7M 27.8M Mar/2026
Integra LifeSciences USD 264.41M 14.44M Mar/2026
J&J USD 21.33B 3.72B Dec/2025
Medtronic USD 6.36B 30M Dec/2025
Merit Medical Systems USD 227M 3.39M Mar/2026
Olympus JPY 334.31B 55.98B Mar/2026
Pfizer USD 16.17B 332M Mar/2026
STAAR Surgical USD 87.55M 37.48M Mar/2026
Stryker USD 3.57B 468M Mar/2026
Surmodics USD 23.56M 288K Jun/2025
Tandem Diabetes Care USD 165.49M 39.55M Dec/2025
Teleflex USD 365.53M 19.94M Mar/2026
Terumo JPY 217.57B 2.28B Mar/2026
Zimmer Biomet Holdings USD 1.73B 24.2M Mar/2026